The global Omega-3 Market is projected to reach USD 8.73 billion by 2031, registering a CAGR of 12.3% during the forecast period. The growth of the omega-3 market is driven by increasing consumer awareness regarding the health benefits of omega-3 fatty acids, particularly their role in cardiovascular, cognitive, and eye health. The growing demand for nutritional supplements, functional foods and beverages, infant nutrition, and pharmaceutical products is further contributing to market expansion.
Omega-3 fatty acids,
particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are
essential fatty acids that the human body cannot efficiently synthesize. This
has increased dependence on dietary sources and externally supplemented omega-3
ingredients. Manufacturers are increasingly incorporating omega-3 oils into
capsules, powders, beverages, fortified foods, and other functional products
while focusing on stability, bioavailability, and efficacy.
Fish oil, krill oil, and
algal oil are among the most widely used sources of omega-3 fatty acids.
Growing consumer preference for clean-label, sustainable, and naturally sourced
ingredients is encouraging manufacturers to diversify their omega-3 portfolios.
Increasing investments in algae-based omega-3 production and advancements in
encapsulation technologies are also expected to create growth opportunities in
the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227
DHA Segment to Register the
Fastest Growth During the Forecast Period
Based on type, the DHA
segment is expected to register the fastest growth during the forecast period.
DHA is a long-chain polyunsaturated omega-3 fatty acid that plays an important
structural role in the brain and retina. Its significance in neurological and
visual development has resulted in increasing demand for DHA across infant
nutrition, dietary supplements, functional foods, and beverages.
DHA is naturally present in
marine sources such as salmon and tuna, as well as in fish oils, dairy
products, and specialty eggs. The growing body of research highlighting the
importance of DHA for brain, eye, and cardiovascular health is increasing consumer
awareness and supporting its incorporation into nutritional products.
The increasing use of DHA in
infant formulas is another major factor contributing to the growth of this
segment. DHA is particularly important during early life stages because of its
role in brain and visual development. Rising demand for premium infant nutrition
products, coupled with increasing consumer awareness about the importance of
essential fatty acids, is expected to support the growth of the DHA segment.
Furthermore, the increasing
availability of algal-derived DHA is expanding options for vegetarian and vegan
consumers. This trend is particularly significant in developed markets, where
demand for sustainable and plant-based nutritional ingredients is increasing.
Infant Formula Segment to
Register the Highest CAGR During the Forecast Period
Based on application, the
infant formula segment is expected to register the highest CAGR during the
forecast period. The growth of this segment can be attributed primarily to
increasing recognition of DHA as an important nutrient fr infant brain and eye
development.
The increasing adoption of
fortified infant formulas containing DHA and EPA is being supported by growing
awareness among parents and healthcare professionals regarding early-life
nutrition. Manufacturers are also developing premium infant formulas designed
to replicate the nutritional composition of human breast milk, further
supporting the use of omega-3 ingredients.
Regulatory developments in
Europe have also contributed to the incorporation of DHA into infant and
follow-on formulas. The European regulatory framework specifies DHA
requirements for infant and follow-on formulas, creating consistent demand for
DHA ingredients from manufacturers operating in the region.
In addition, rising demand
for organic, clean-label, and nutritionally enhanced infant formulas is
creating opportunities for omega-3 suppliers. Emerging economies are also
expected to contribute to market growth as birth rates, household purchasing
power, awareness of infant nutrition, and access to premium nutritional
products increase.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227
Europe to Account for a
Significant Share of the Omega-3 Market
Europe is expected to
account for a significant share of the global Omega-3 Market during the
forecast period. The regional market is supported by high consumer awareness,
stringent regulatory standards, growing demand for preventive healthcare, and
strong adoption of dietary supplements and functional foods.
European consumers are
increasingly seeking premium nutritional products containing recognizable and
sustainably sourced ingredients. This trend is driving demand for fish oil as
well as alternative sources such as algal-derived omega-3. The increasing vegetarian
and flexitarian populations in countries such as Germany, the UK, and France
are further supporting demand for algae-based omega-3 products.
The presence of established
omega-3 manufacturers and ongoing investments in research and development are
strengthening the European market. Companies are focusing on developing
innovative formulations and expanding production capacities to meet the increasing
demand for omega-3 ingredients across dietary supplements, functional foods and
beverages, infant nutrition, and pharmaceutical applications.
Leading Omega-3
Companies:
The report profiles key
players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich
(Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway),
Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD
Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc.
(Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega
Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana
Inc. (US), and AlgaeCytes Limited (UK).
